India markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
109.03-3.30 (-2.94%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close112.33
Open113.90
Bid109.10 x 1200
Ask110.29 x 800
Day's range109.03 - 114.98
52-week range28.00 - 131.00
Volume1,007,627
Avg. volume3,236,255
Market cap26.253B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • J&J single-dose COVID-19 vaccine gets green light from FDA
    Yahoo Finance

    J&J single-dose COVID-19 vaccine gets green light from FDA

    Johnson & Johnson's (JNJ) single-dose COVID-19 vaccine was given an emergency use authorization (EAU) Saturday evening by U.S. Food and Drug Administration (FDA), making it the third vaccine available in the U.S.

  • Pfizer-BioNTech testing booster of their COVID-19 vaccine in new trial
    Reuters

    Pfizer-BioNTech testing booster of their COVID-19 vaccine in new trial

    Pfizer Inc and BioNTech SE said on Thursday they are testing a third dose of their COVID-19 vaccine to better understand the immune response against new variants of the virus. They are also in talks with regulatory authorities about testing a vaccine modified to protect specifically against the highly transmissible new variant found in South Africa and elsewhere, known as B.1.351, as a second arm of the same study. The companies believe their current two-dose vaccine will work against the South African variant as well as one found in the United Kingdom and elsewhere.

  • Moderna expands vaccine production, sets 2022 target of 1.4B doses
    Yahoo Finance

    Moderna expands vaccine production, sets 2022 target of 1.4B doses

    Moderna announces new expansion plans, and a study for its booster shot that targets the South African variant.